Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FSZ81
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,899
Award facts
- Contract value 100% obligated
- $98,898.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $98,898.60 on September 15, 2025, for the supply of Entyvio 300 mg vials. The contract is a firm fixed-price delivery order with an ultimate completion date of October 6, 2025, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA's SPE2DB program, a $500 million single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities.
Entyvio (vedolizumab) is a biologic medication primarily used to treat inflammatory bowel diseases, and this delivery order fulfills medical supply requirements for military health facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts to deliver prescription drugs, biologics, and specialized medical products to DoD healthcare systems nationwide. The company's robust federal contracting portfolio and established position as a woman-owned small business enable it to compete effectively in federal procurement markets while meeting the Defense Logistics Agency's ongoing pharmaceutical distribution needs.
Quick answers
Who was awarded contract SPE2DB25FSZ81?
SPE2DB25FSZ81 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FSZ81 worth?
The government has obligated $98,899 on SPE2DB25FSZ81.
Is contract SPE2DB25FSZ81 an order under another contract?
Yes. SPE2DB25FSZ81 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ81 competed?
The extent of competition for SPE2DB25FSZ81 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award